Stereotactic ablative radiotherapy combined with fruquintinib and tislelizumab in metastatic colorectal cancer: Preliminary findings from a single-arm, prospective phase II trial (RIFLE)

被引：0
|
作者：
Chen, Y. [1 ]
Wang, K. [1 ]
Zhiyuan, Z. [2 ]
Zhang, H. [1 ]
Yang, W. [1 ]
Wu, R. [1 ]
Zhou, M. [1 ]
Zhang, Z. [1 ]
Xia, F. [1 ]
机构：
[1] Fudan Univ, Shanghai Canc Ctr, Dept Radiat Oncol, Shanghai, Peoples R China
[2] Fudan Univ, Shanghai Canc Ctr, Dept Radiat Therapy, Shanghai, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.1828
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
638P
引用
收藏
页码：S451 / S451
页数：1
相关论文
共 50 条
  • [1] Stereotactic ablative radiotherapy combined with fruquintinib and tislelizumab in metastatic colorectal cancer: Updated findings from a single-arm, prospective phase II trial (RIFLE)
    Chen, Y.
    Wang, K.
    Zhang, Z.
    Zhang, H.
    Yang, W.
    Wu, R.
    Zhou, M.
    Zhang, Z.
    Xia, F.
    ANNALS OF ONCOLOGY, 2024, 35 : S449 - S449
  • [2] Stereotactic ablative radiotherapy combined with fruquintinib and tislelizumab in metastatic colorectal cancer: Updated findings from a single-arm, prospective phase II trial (RIFLE)
    Chen, Yajie
    Wang, Kun
    Zhang Zhiyuan
    Zhang, Hui
    Yang, Wang
    Wu, Ruiyan
    Zhou, Menglong
    Zhang, Zhen
    Xia, Fan
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [3] Stereotactic Ablative Radiotherapy Combined with Fruquintinib and Tislelizumab in Metastatic Colorectal Cancer: Updated Findings from a Single-Arm, Prospective Phase II Trial (RIFLE)
    Chen, Y.
    Wang, K.
    Zhang, Z.
    Zhang, H.
    Yang, W.
    Wu, R.
    Zhou, M.
    Zhang, Z.
    Xia, F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E432 - E433
  • [4] RIFLE: a Phase II trial of stereotactic ablative radiotherapy combined with fruquintinib and tislelizumab in metastatic colorectal cancer
    Wang, Kun
    Chen, Yajie
    Zhang, Zhiyuan
    Wu, Ruiyan
    Zhou, Menglong
    Yang, Wang
    Wan, Juefeng
    Shen, Lijun
    Zhang, Hui
    Wang, Yan
    Han, Xu
    Wang, Jiazhou
    Zhang, Zhen
    Xia, Fan
    GASTROENTEROLOGY REPORT, 2023, 11
  • [5] Stereotactic body radiation therapy combined with chemotherapy and tislelizumab in metastatic nasopharyngeal carcinoma: A prospective, single-arm, phase II study
    Liu, T.
    Tao, C.
    Qin, W.
    Jiang, F.
    ANNALS OF ONCOLOGY, 2024, 35 : S632 - S633
  • [6] Raltitrexed, S-1 and fruquintinib (RSF) in the treatment of refractory metastatic colorectal cancer: study protocol for a multicenter, prospective, single-arm, phase II trial
    Leng, Weibing
    Wen, Zhenpeng
    Wang, Han
    Cao, Peng
    Liu, Jiyan
    Luo, Deyun
    Qiu, Meng
    BMC CANCER, 2025, 25 (01)
  • [7] Fecal microbiota transplantation plus tislelizumab and fruquintinib in refractory microsatellite stable metastatic colorectal cancer: an open-label, single-arm, phase II trial (RENMIN-215)
    Zhao, Wensi
    Lei, Jun
    Ke, Shaobo
    Chen, Yuan
    Xiao, Jiping
    Tang, Ze
    Wang, Li
    Ren, Yiping
    Alnaggar, Mohammed
    Qiu, Hu
    Shi, Wei
    Yin, Lei
    Chen, Yongshun
    ECLINICALMEDICINE, 2023, 66
  • [8] Tislelizumab combined with gemcitabine and albumin paclitaxel as preoperative therapy for patients with borderline resectable pancreatic cancer: A prospective, single-arm, phase II trial
    He, Yonggang Gang
    Huang, Xiaobing
    Zheng, Lu
    Li, Jing
    Zhao, Chongyu
    Li, Ying
    Zuo, Guohua
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [9] Tislelizumab combined with induction chemotherapy and concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: A prospective, single-arm, phase II trial
    Li, M.
    Qu, S.
    Lan, G.
    Shi, M.
    Wang, Y.
    Ban, M.
    Weng, J.
    Wei, J.
    Huang, W.
    Gui, Z.
    Mao, X.
    Huang, X.
    Xie, S.
    Wang, H.
    Huang, B.
    Qin, Y.
    ANNALS OF ONCOLOGY, 2024, 35 : S632 - S632
  • [10] Efficacy and safety of radiotherapy combined with raltitrexed and irinotecan for treating unresectable recurrent colorectal cancer: a single-arm phase II trial
    Li, Xinghui
    Shen, Jinwen
    Xia, Fan
    Zhu, Ji
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022, 13 (03) : 1112 - 1120
12345